You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 15, 2025

Drug Price Trends for MINOCYCLINE HCL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MINOCYCLINE HCL

Average Pharmacy Cost for MINOCYCLINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MINOCYCLINE HCL 75 MG TABLET 64380-0155-01 0.38070 EACH 2024-12-18
MINOCYCLINE HCL 100 MG TABLET 13668-0487-50 0.42572 EACH 2024-12-18
MINOCYCLINE HCL 100 MG TABLET 57664-0856-85 0.42572 EACH 2024-12-18
MINOCYCLINE HCL 100 MG TABLET 64380-0156-01 0.42572 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for MINOCYCLINE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
MINOCYCLINE HCL 55MG TAB,SA Golden State Medical Supply, Inc. 68180-0460-06 30 355.89 11.86300 EACH 2023-06-16 - 2028-06-14 FSS
MINOCYCLINE HCL 65MG TAB,SA Amneal Pharmaceuticals of New York, LLC 00115-9935-08 30 97.97 3.26567 EACH 2023-01-01 - 2027-06-30 FSS
MINOCYCLINE HCL 115MG TAB,SA Amneal Pharmaceuticals of New York, LLC 00115-9936-08 30 19.08 0.63600 EACH 2022-09-27 - 2027-06-30 Big4
MINOCYCLINE HCL 115MG TAB,SA Amneal Pharmaceuticals of New York, LLC 00115-9936-08 30 97.97 3.26567 EACH 2022-09-27 - 2027-06-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Minocycline Hydrochloride Market Analysis and Price Projections

Market Overview

Minocycline hydrochloride, a tetracycline antibiotic, is widely used to treat various bacterial infections, including those affecting the skin, respiratory tract, gallbladder, and urinary tract. The market for minocycline hydrochloride is experiencing steady growth, driven by increasing demand for effective antibacterial treatments.

Market Size and Growth Projections

The minocycline hydrochloride market is forecasted to reach significant milestones in the coming years. According to industry reports, the market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 2.3% to 3.10% between 2022 and 2028, reaching approximately $18.8 million by 2027[1][4].

Segment Analysis

By Application

The market is segmented into several applications, including:

  • Minocycline Hydrochloride Tablets: Held the largest share of 38% in 2021, primarily due to their widespread use in treating bacterial infections[1].
  • Minocycline Hydrochloride Capsules: Another significant segment, these capsules are preferred for their ease of administration and bioavailability.
  • Minocycline Hydrochloride Gel: Used primarily for topical applications, especially in treating acne and other skin infections[3][4].

By Type

The market is also segmented by type:

  • Pharmaceutical Grade: This segment dominates the market due to the high demand for minocycline hydrochloride in medical treatments.
  • Industrial Grade: Although smaller, this segment is crucial for non-pharmaceutical applications[1][3].

By Geography

Geographically, the market is divided into:

  • Asia-Pacific (APAC): Dominated the market in 2021 with a 37% share, driven by countries like China and India, which are major producers of active pharmaceutical ingredients (APIs)[1].
  • North America: Holds a significant share due to high consumption for treating urinary tract infections and severe acne.
  • Europe: The second-largest market, driven by the treatment of respiratory diseases and the presence of advanced medical facilities[4].

Price Projections and Cost Analysis

The prices of minocycline hydrochloride vary based on the form and dosage of the medication.

Oral Capsules and Tablets

  • 50 mg Oral Capsules: Prices range from $0.86 to $1.48 per unit, depending on the quantity[2].
  • 50 mg Oral Tablets: Prices start from $2.51 per unit for a 90-tablet supply[2].
  • Extended Release Tablets: Prices vary from $12.59 to $33.48 per unit, depending on the dosage and quantity[2].

Intravenous Powder for Injection

  • The cost for Minocin 100 mg intravenous powder for injection is around $2,651 for a supply of 10 powder for injection[5].

Impact of COVID-19

The COVID-19 pandemic had a noticeable impact on the minocycline hydrochloride market. The temporary shutdown of industrial activities and the shift in manufacturing units to produce pandemic-related medicines affected the demand and supply chain, restricting market growth in 2021[1].

Market Drivers and Restraints

Drivers

  • Increasing Bacterial Infections: The rise in bacterial infections is a significant driver for the market.
  • Advancements in Technology: Improvements in treatment and diagnosis technologies are boosting market growth.
  • Growing Healthcare Expenditure: Increasing healthcare spending, especially in the APAC region, is driving the market forward[4].

Restraints

  • Adverse Effects: Minocycline hydrochloride can cause serious side effects such as life-threatening skin rashes and permanent tooth discoloration in children under eight years old[1].
  • High Cost: The high cost of the drug and raw materials, along with strict government regulations, can hamper market growth[4].

Competitive Landscape

The competitive landscape of the minocycline hydrochloride market is characterized by:

  • Technology Launches and R&D: Major players are investing heavily in research and development, launching new technologies, and acquiring other companies to strengthen their market position[1].
  • Global Presence: Companies with a strong global presence, such as those in North America, Europe, and APAC, are dominant in the market[4].

Key Takeaways

  • The minocycline hydrochloride market is expected to grow steadily, driven by increasing demand for antibacterial treatments.
  • Asia-Pacific is expected to dominate the market in the coming years.
  • The pharmaceutical grade segment will continue to be the largest due to high medical demand.
  • Adverse effects and high costs are significant restraints to market growth.

FAQs

1. What is minocycline hydrochloride used for? Minocycline hydrochloride is used to treat various bacterial infections, including those affecting the skin, respiratory tract, gallbladder, and urinary tract.

2. What is the projected market size of minocycline hydrochloride by 2027? The market size is forecasted to reach approximately $18.8 million by 2027, growing at a CAGR of 2.3%[1].

3. Which region dominates the minocycline hydrochloride market? Asia-Pacific (APAC) dominated the market in 2021 with a 37% share, driven by countries like China and India[1].

4. What are the common side effects of minocycline hydrochloride? Minocycline hydrochloride can cause serious side effects such as life-threatening skin rashes and permanent tooth discoloration in children under eight years old[1].

5. How does the COVID-19 pandemic impact the minocycline hydrochloride market? The COVID-19 pandemic affected the demand and supply chain, restricting market growth in 2021 due to the temporary shutdown of industrial activities and the shift in manufacturing units to produce pandemic-related medicines[1].

Citations

  1. IndustryARC, Minocycline Hydrochloride Market Size Report, 2022-2027.
  2. Drugs.com, Minocycline Prices, Coupons, Copay Cards & Patient Assistance.
  3. MarketResearchIntellect, Global minocycline hydrochloride market size and forecast.
  4. Data Bridge Market Research, Global Minocycline Hydrochloride Market - Industry Trends and Forecast to 2028.
  5. Drugs.com, Minocin Prices, Coupons, Copay Cards & Patient Assistance.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.